用户验证的应用
经验证应用
| 项目 | 详情 |
|---|---|
| WB | 1:1000-1:5000 |
| ELISA | 1:5000-1:10000 |
应用说明
IHC, FCM, IF, IP et al. applications haven't been validated. (Antibody's applications haven't been validated with corresponding virus positive samples. Optimal concentrations/dilutions should be determined by the end user.)
推荐稀释说明
Optimal concentrations/dilutions should be determined by the end user.
详细信息
特异性
SARS-CoV-2 Spike RBD Has cross-reactivity in ELISA and WB with SARS-CoV Spike S1 (His Tag) (Cat# 40150-V08B1) SARS-CoV Spike RBD (His Tag) (Cat# 40150-V08B2) SARS-CoV-2 (2019-nCoV) Spike S1 (His Tag) (Cat# 40591-V08H)
制备方法
Produced in rabbits immunized with purified, recombinant SARS-CoV-2 / 2019-nCoV Spike/RBD Protein (YP_009724390.1; Arg319-Phe541). The specific IgG was purified by SARS-CoV-2 / 2019-nCoV Spike/RBD affinity chromatography.
运输条件
This antibody is shipped as liquid solution at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
背景信息
The spike (S) glycoprotein of coronaviruses contains protrusions that will only bind to certain receptors on the host cell. Known receptors bind S1 are ACE2 (angiotensin-converting enzyme 2), DPP4 (dipeptidyl peptidase-4), APN (aminopeptidase N), CEACAM (carcinoembryonic antigen-related cell adhesion molecule), Sia (sialic acid), O-ac Sia (O-acetylated sialic acid). The spike is essential for both host specificity and viral infectivity. The term 'peplomer' is typically used to refer to a grouping of heterologous proteins on the virus surface that function together. The spike (S) glycoprotein of coronaviruses is known to be essential in the binding of the virus to the host cell at the advent of the infection process. It's been reported that SARS-CoV-2 (COVID-19 coronavirus, 2019-nCoV) can infect the human respiratory epithelial cells through interaction with the human ACE2 receptor. The spike protein is a large type I transmembrane protein containing two subunits, S1 and S2. S1 mainly contains a receptor binding domain (RBD), which is responsible for recognizing the cell surface receptor. S2 contains basic elements needed for the membrane fusion. The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity. The main functions for the Spike protein are summarized as: Mediate receptor binding and membrane fusion; Defines the range of the hosts and specificity of the virus; Main component to bind with the neutralizing antibody; Key target for vaccine design; Can be transmitted between different hosts through gene recombination or mutation of the receptor binding domain (RBD), leading to a higher mortality rate. References Shen S, et al . (2007) Expression, glycosylation, and modification of the spike (S) glycoprotein of SARS CoV. Methods Mol Biol. 379: 127-35. Du L, et al . (2009) The spike protein of SARS-CoV--a target for vaccine and therapeutic development. Nat Rev Microbiol. 7 (3): 226-36. Xiao X, et al . (2004) The SARS-CoV S glycoprotein. Cell Mol Life Sci. 61 (19-20): 2428-30.
文献引用 (94)
Leveraged Vaccination to Alleviate Original Antigenic Sin for Enhancing Broad-Neutralizing Antibody Response against SARS-CoV-2 Omicron Subvariants.
利用疫苗接种减轻原始抗原罪,以增强针对 SARS-CoV-2 Omicron 亚型的广谱中和抗体反应
Immunogenicity and safety of a live-attenuated SARS-CoV-2 vaccine candidate based on multiple attenuation mechanisms
基于多重减毒机制的 SARS-CoV-2 减毒活疫苗候选物的免疫原性和安全性
Capture of fusion-intermediate conformations of SARS-CoV-2 spike requires receptor binding and cleavage at either the S1/S2 or S2' site.
捕获 SARS-CoV-2 刺突蛋白的融合中间构象需要受体结合,并在 S1/S2 或 S2' 位点进行切割
Characterization of spike S1/S2 processing and entry pathways of lentiviral pseudoviruses bearing seasonal human coronaviruses NL63, 229E, and HKU1 spikes.
对携带季节性人类冠状病毒 NL63、229E 和 HKU1 刺突蛋白的慢病毒假病毒的刺突蛋白 S1/S2 加工和进入途径进行表征
Tubeimosides are pan-coronavirus and filovirus inhibitors that can block their fusion protein binding to Niemann-Pick C1
土贝莫司苷是泛冠状病毒和丝状病毒抑制剂,可以阻断其融合蛋白与尼曼匹克 C1 的结合
A cardiotoxicity-eliminated ACE2 variant as a pan-inhibitor against coronavirus cell invasion
消除心脏毒性的 ACE2 变体作为针对冠状病毒细胞入侵的全抑制剂
Development of an engineered extracellular vesicles-based vaccine platform for combined delivery of mRNA and protein to induce functional immunity
开发一种基于工程化细胞外囊泡的疫苗平台,用于联合递送mRNA和蛋白质以诱导功能性免疫
An intranasal combination vaccine induces systemic and mucosal immunity against COVID-19 and influenza
鼻内联合疫苗可诱导针对新冠病毒和流感的全身性和黏膜免疫力
Dynamin independent endocytosis is an alternative cell entry mechanism for multiple animal viruses
动力蛋白独立的内吞作用是多种动物病毒的替代细胞进入机制
- 1
- 2
- 3
- 4
- 5
- 6
- 10